ARAY - Accuray Quarterly EPS earnings growth
By outsourcing the production of components to external contractors, Accuray Incorporated focuses on protecting its proprietary software. The quarterly change in earnings per share reflects the dynamics of this process, and the current value of this metric is 139.40. Market capitalization is based on the delivery of CyberKnife systems to medical centers, while technological growth is driven by the implementation of AI for precision tracking of neoplasms.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_ARAY_-_Accuray-Incorporated_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Accuray Incorporated (ARAY): Quarterly EPS earnings growth from 07/04/2022 to 11/13/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Accuray, Inc. (ARAY)
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital Accuray Incorporated|ARAY - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Accuray Incorporated|ARAY - Company Aggregate Debts|Debt to Book Capitalization Ratio Accuray Inc.|ARAY - Company Long-Term Loans and Borrowings|Company Short-Term Debts Accuray Incorporated|Quick Liquidity Indicator accuray.com
- earnings and valuation multiples indicators:
ARAY - Company Net Income|Future Profit Accuray Incorporated|ARAY - Company Value to Net Income|Forward P/E Multiple Accuray Inc.|ARAY - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Accuray Inc.|ARAY - Operating profit before amortization|Net earnings per share (EPS TTM) Accuray Incorporated|ARAY - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months accuray.com|ARAY - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Accuray Incorporated
Initial company analysis:Accuray Incorporated
A comparative asset analysis requires an evaluation of quarterly net earnings per share dynamics. This metric measures the rate of change in profitability, reflecting the business's sensitivity to the cost of capital and macroeconomic pressure. For Accuray Incorporated (ARAY), this momentum depends on the scaling of CyberKnife systems and the implementation of AI technologies. Investors should interpret a shift in the quarterly EPS level as a balance between operating expenses and expansion.
Who Accuray Incorporated competes with
BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth urogen.com (URGN)|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|PSNL - Year-over-year net earnings per share growth for the last 12 months|Erasca Corp - Quarterly EPS earnings growth|Delcath Corp (DCTH) - Year-over-year net earnings per share growth for the last 12 months|YMAB (Y-mAbs Therapeutics) - Year-over-year net earnings per share growth for the last 12 months|aurabiosciences.com (AURA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|SLS: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACTU|Quarterly EPS earnings growth Citius Oncology Inc (CTOR)|TuHURA Biosciences - Year-over-year net earnings per share growth for the last 12 months|protaratx.com (TARA) - Earnings per share growth in annualized terms for the last twelve months|FATE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months WHWK (Aadi Bioscience Inc)|TCRX: Quarterly EPS earnings growth|CSBR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months XBiotech Inc|Year-over-year earnings per share growth for the last 12 months CVM (CEL-SCI Corp)|Quarterly EPS earnings growth OSTX|Year-over-year net earnings per share growth for the last 12 months Radiopharm Theranostics Ltd RADX|Year-over-year earnings per share growth for the last twelve months Artiva Biotherapeutics ARTV|Adlai Nortye Ltd (ANL) - Earnings per share growth in annualized terms for the last twelve months|VERU - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months TPST (tempesttx.com)|xiliotx.com (XLO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months RENB (Renovaro)|Year-over-year earnings per share growth for the last twelve months Mural Oncology PLC|Earnings per share growth in annualized terms for the last twelve months Kairos Pharma Inc KAPA|Year-over-year earnings per share growth for the last twelve months OnKure Therapeutics Inc (OKUR)|GDTC (w2.cytomed.sg) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CRIS (Curis)|Quarterly EPS earnings growth Apollomics Inc. APLM|THAR: Year-over-year net earnings per share growth for the last 12 months|Advanced Biomed Inc - Year-over-year earnings per share growth rate for the last twelve months|GNPX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Calidi Biotherapeutics, Inc. (CLDI)|SBFM (Sunshine Biopharma) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months XBIO (Xenetic Bio)|Quarterly EPS earnings growth SLRX|Quarterly EPS earnings growth Kitov Pharma (PPBT)|Year-over-year earnings per share growth for the last twelve months American Oncology Network, Inc. AONC|Year-over-year earnings per one share growth for the last 12 months BGNE|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|ELEV - Quarterly EPS earnings growth|ICAD (icadmed.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Ikena Oncology (IKNA)|NTBL (Notable Labs, Ltd.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta (VIRX)|Quarterly EPS earnings growth MOR|Quarterly EPS earnings growth NAYA Biosciences Inc (NAYA)|Year-over-year earnings per share growth for the last twelve months Ascentage Pharma Group Ltd AAPGV
